[HTML] nih.gov

Use of aspirin in reduction of mortality of COVID‐19 patients: A meta‐analysis

R Srivastava, A Kumar - International journal of clinical practice, 2021 - Wiley Online Library
COVID‐19 infection, affecting every one of us from the last year. Emerging reports have
indicated thromboembolism in serious cases of COVID‐19. The aspirin is useful to reduce …
被引用次数：53 相关文章 所有 8 个版本
[HTML] springer.com

[HTML][HTML] Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis

S Ma, W Su, C Sun, S Lowe, Z Zhou, H Liu… - European Journal of …, 2022 - Springer
Purpose The coronavirus disease 2019 (COVID-19) pandemic has shown unprecedented
impact world-wide since the eruption in late 2019. Importantly, emerging reports suggest an …
被引用次数：25 相关文章 所有 12 个版本
[HTML] sciencedirect.com

[HTML][HTML] The effects of aspirin on the outcome of COVID-19: a systematic review and meta-analysis

I Wijaya, R Andhika, I Huang, A Purwiga… - … epidemiology and global …, 2021 - Elsevier
Background Repurposing the use of aspirin to treat hospitalized patients with COVID-19 is a
sensible approach. However, several previous studies showed conflicting results. This meta …
被引用次数：50 相关文章 所有 7 个版本
[PDF] cardiff.ac.uk

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

PW Horby, G Pessoa-Amorim, N Staplin… - The …, 2021 - orca.cardiff.ac.uk
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
被引用次数：36 相关文章 所有 5 个版本
[HTML] thelancet.com

[HTML][HTML] Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

O Abani, A Abbas, F Abbas, M Abbas, S Abbasi… - The Lancet, 2022 - thelancet.com
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
被引用次数：47 相关文章 所有 4 个版本
[HTML] nih.gov

[HTML][HTML] Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group - Lancet (London, England), 2022 - ncbi.nlm.nih.gov
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
被引用次数：197 相关文章 所有 19 个版本
[HTML] nih.gov

Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19

M Haji Aghajani, O Moradi, H Amini… - Journal of Medical …, 2021 - Wiley Online Library
Hypercoagulability and thrombosis caused by coronavirus disease 2019 (COVID‐19) are
related to the higher mortality rate. Because of limited data on the antiplatelet effect, we …
被引用次数：47 相关文章 所有 7 个版本
[HTML] springer.com

[HTML][HTML] Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

CS Kow, SS Hasan - Journal of thrombosis and thrombolysis, 2021 - Springer
Globally, there have been close to 130 million reported cases of coronavirus disease 2019
(COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce …
被引用次数：40 相关文章 所有 7 个版本
[HTML] lww.com

[HTML][HTML] Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19

Q Liu, N Huang, A Li, Y Zhou, L Liang, X Song, Z Yang… - Medicine, 2021 - journals.lww.com
Effect of low-dose aspirin on mortality and viral duration o... : Medicine Effect of low-dose
aspirin on mortality and viral duration of the hospitalized adults with COVID-19 : Medicine Log …
被引用次数：54 相关文章 所有 6 个版本
[HTML] plos.org

[HTML][HTML] Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration

TF Osborne, ZP Veigulis, DM Arreola, SM Mahajan… - PloS one, 2021 - journals.plos.org
There is growing evidence that thrombotic and inflammatory pathways contribute to the
severity of COVID-19. Common medications such as aspirin, that mitigate these pathways …
被引用次数：108 相关文章 所有 14 个版本